封面
市場調查報告書
商品編碼
1391919

鼻乳液噴霧市場:依產品類型、依應用、依年齡層、依配銷通路、按地區

Nasal Lotion Spray Market, By Product Type, By Application (Allergy Relief, Sinusitis Treatment, Cold & Flu Relief, Hay Fever Relief and Others, By Age Group, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年全球鼻腔噴霧劑市場規模為107.8億美元,預計到2030年將達到171.1億美元,在預測期內(2023-2030)成長6.8%年複合成長率(CAGR)的

報告範圍 報告詳情
基準年 2022年 2023年市場規模 107.8億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 6.80% 2030年市場規模預測 171.1億美元
圖 1. 2023 年鼻腔乳液噴霧劑的全球市場佔有率(按地區分類)
鼻腔乳液噴霧市場-IMG1

由於呼吸道疾病和過敏的盛行率不斷上升,過去幾年鼻腔乳液噴劑的全球市場顯著成長。鼻腔乳液噴霧可快速緩解鼻塞和鼻道內的稀薄粘液,使呼吸更容易。它含有生理食鹽水和其他藥物,可以溶解黏液,使呼吸更容易。與口服藥物相比,鼻洗劑和噴霧劑擴大被採用,因為它們直接在鼻腔中局部起作用。此外,輸送機制的創新使滴鼻劑的使用更加方便。

市場動態:

鼻塞、過敏和其他鼻部疾病盛行率的上升推動了鼻腔乳液噴劑的全球市場。污染水平上升、氣候條件變化和久坐的生活方式導致鼻部問題增加。洗鼻劑和噴霧劑因其快速緩解和局部作用而被廣泛用於治療鼻部症狀。然而,在新興市場,人們缺乏對鼻腔乳液噴霧劑優於傳統滴鼻劑的認知,這可能會阻礙市場成長。另一個挑戰是替代治療方案的可用性。然而,隨著提高療效和治療持續時間的研究和開發工作正在進行中,市場擴張的機會很多。主要企業正在投資推出具有先進配方的新產品,以利用現有機會。

鼻部疾病盛行率的增加、老年人口的增加、對鼻腔乳液噴霧劑的需求增加、人們意識的提高以及新產品的推出預計將在預測期內推動全球鼻腔乳液噴霧劑市場。

市場公司正忙於獲得新開發產品的核准,預計這將在預測期內推動全球鼻腔乳液噴霧市場的成長。 2021 年,藥廠 Cipla Limited 宣布其舒馬曲坦鼻噴霧20 mg 的簡略新藥認證(ANDA) 已獲得美國食品藥物管理局(FDA) 的最終核准。 Cipla 的 Sumatriptan鼻噴霧USP 20mg 是GlaxoSmithKline PlcImitrex鼻噴霧的 AB 級學名藥。

然而,低認知度和可用性低預計將阻礙預測期內全球鼻腔乳液噴劑市場的成長。

本研究的主要特點

  • 該報告詳細分析了全球鼻乳液噴霧市場,並提供了以2022年為基準年的預測期(2023-2030)的市場規模和年複合成長率(CAGR%)。
  • 它還闡明了各個細分市場的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 我們根據公司亮點、產品系列、主要亮點、績效和策略等參數,對全球鼻乳液噴霧市場的主要企業進行了分析。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的資訊。
  • 全球鼻乳液噴霧市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球鼻乳液噴霧市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章 全球鼻洗劑市場 -冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球鼻腔乳液噴霧市場,依產品類型,2023-2030

  • 生理食鹽水
  • 類固醇滴鼻劑
  • 抗組織胺滴鼻劑
  • 減充血鼻噴霧噴霧劑
  • 天然/有機滴鼻劑
  • 其他(羥甲唑啉、去氧腎上腺素等)

第6章 全球鼻腔乳液噴霧市場,依應用分類,2018-2030

  • 緩解過敏
  • 鼻竇的治療
  • 緩解感冒和流感
  • 緩解花粉症
  • 其他(防鼻子乾燥/發癢等)

第7章 全球鼻腔乳液噴霧市場,依年齡段,2018-2030

  • 成人
  • 孩子們
  • 嬰兒

第8章 全球鼻腔乳液噴霧市場,依配銷通路,2018-2030

  • 醫院藥房
  • 零售藥房
  • 電子商務
  • 其他(大型超市、便利商店等)

第9章 全球鼻腔乳液噴霧市場,按地區,2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 中東和非洲
  • GCC
  • 以色列
  • 南非
  • 北非
  • 中部非洲
  • 其他中東地區

第10章 競爭形勢

  • 公司簡介
    • GlaxoSmithKline plc
    • Johnson &Johnson
    • Pfizer Inc.
    • Novartis AG
    • AstraZeneca PLC
    • Sanofi SA
    • Merck &Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Perrigo Company plc
    • Prestige Consumer Healthcare Inc
    • NeilMed Pharmaceuticals, Inc
    • Church &Dwight Co., Inc
    • Navage, Inc.
    • Xlear, Inc.

第11章章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5946

Global nasal lotion spray market size is estimated to be valued at US$ 10.78 Bn in 2023 and is projected to reach US$ 17.11 Bn by 2030, exhibiting compound annual growth rate (CAGR) of 6.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 10.78 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.80% 2030 Value Projection: US$ 17.11 Bn
Figure 1. Global Nasal Lotion Spray Market Share (%), By Region, 2023
Nasal Lotion Spray Market - IMG1

Global nasal lotion spray market has been growing significantly over the past few years due to rising prevalence of respiratory diseases and allergies. Nasal lotion sprays provide quick relief from congestion and allow easy breathing by thinning the mucus in nasal passageways. They contain saline solutions or other medications that help loosen mucus and ease respiration. Nasal lotion sprays are increasingly being adopted over oral medications owing to their localized and direct effect on nasal cavities. Furthermore, innovations in delivery mechanisms have made nasal sprays more convenient to use.

Market Dynamics:

The global nasal lotion spray market is driven by rising incidence of nasal congestion, allergies, and other nasal disorders. Growing pollution levels, changing climate conditions, and sedentary lifestyles have contributed to increased nasal problems. Nasal lotion sprays are widely used for treating nasal symptoms owing to quick relief and localized action. However, low awareness about benefits of nasal lotion sprays over traditional nasal sprays in developing regions may hinder market growth. Moreover, availability of alternative treatment options poses a challenge. Nonetheless, ongoing R&D to enhance efficacy and duration of treatment presents high opportunity for market expansion. Key players are investing in new product launches with advanced formulations to capitalize on existing opportunities.

Increasing prevalence of nasal disorders, growing geriatric (aging) population, increasing demand for nasal lotion sprays, growing awareness among people, and introduction of novel products are major factors expected to drive growth of the global nasal lotion spray market during the forecast period.

Market players are indulged in receiving approval for their new developed product and this is expected to drive the growth of the global nasal lotion spray market, over the forecast period. In 2021, Cipla Limited, a pharmaceutical company, announced that it received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the U.S. Food and Drug Administration (U.S. FDA). Cipla's Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.

However, lack of awareness and limited availability is expected to hamper the growth of the global nasal lotion spray market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global nasal lotion spray market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global nasal lotion spray market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Perrigo Company plc, Prestige Consumer Healthcare Inc., NeilMed Pharmaceuticals, Inc., Church & Dwight Co., Inc., Navage, Inc. and Xlear, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global nasal lotion spray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal lotion spray market

Detailed Segmentation:

  • By Product Type:
    • Saline Solution
    • Steroid Nasal Sprays
    • Antihistamine Nasal Sprays
    • Decongestant Nasal Sprays
    • Natural/Organic Nasal Sprays
    • Others (Oxymetazoline, Phenylephrine and Others)
  • By Application:
    • Allergy Relief
    • Sinusitis Treatment
    • Cold & Flu Relief
    • Hay Fever Relief
    • Others (Nasal dryness & itch relief and Others)
  • By Age Group:
    • Adults
    • Children
    • Infants
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • E-commerce
    • Others (Hypermarkets, Convenience Stores, among others)
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Nasal Lotion Spray Market:
    • GlaxoSmithKline plc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • AstraZeneca PLC
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Perrigo Company plc.
    • Prestige Consumer Healthcare Inc.
    • NeilMed Pharmaceuticals, Inc.
    • Church & Dwight Co., Inc.
    • Navage, Inc.
    • Xlear, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Age Group
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Nasal Lotion Spray Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Nasal Lotion Spray Market, By Product Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Saline Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Steroid Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Antihistamine Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Decongestant Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Natural/Organic Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Oxymetazoline, Phenylephrine and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Nasal Lotion Spray Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Allergy Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Sinusitis Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cold & Flu Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hay Fever Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Nasal dryness & itch relief and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Nasal Lotion Spray Market, By Age Group, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Children
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Nasal Lotion Spray Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • E-commerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Hypermarkets, Convenience Stores, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Nasal Lotion Spray Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Sub-region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Sub-region, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
  • GCC
  • Israel
  • South Africa
  • North Africa
  • Central Africa
  • Rest of Middle East

10. Competitive Landscape

  • Company Profile
    • GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • AstraZeneca PLC
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Perrigo Company plc
    • Prestige Consumer Healthcare Inc
    • NeilMed Pharmaceuticals, Inc
    • Church & Dwight Co., Inc
    • Navage, Inc.
    • Xlear, Inc.
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us